Opus Genetics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-10.2% -$437K
$4M
Cost of Revenue
—
R&D↑+48.3% +$3M
$10M
D&A↑+30.0% +$3K
$13K
Operating Income↓-3.8% -$302K
$-8M
EBITDA↑+30.0% +$3K
$13K
Interest Expense
$61K
Interest Income
—
Other Income/Expense↓-1978.9% -$10M
$-9M
Pretax Income↓-131.9% -$10M
$-17M
Tax Provision
$0
Net Income↓-131.9% -$10M
$-17M
Operating Margin↓-62.8pts
-269.9%
Net Margin↓-372.3pts
-566.9%
Effective Tax Rate↑+0.0pts
0.0%
DTA Valuation Allowance
—
NOL Carryforwards
—
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-11.7pts
-6.8%
Operating Lease Cost↑+37.0% +$27K
$100K
Revenue YoY Variation↓-164.6pts
-10.2%
Income YoY Variation↑+221.6pts
-3.8%
Revenue QoQ Variation↑+14.3pts
25.5%
Income QoQ Variation↑+2.9pts
6.7%